V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006292 | 220002436 | 1.5 | 55 | Curative (C) | 2014-11-15 | 2014-11-15 | FLAG + Idarubicin | null | N | 220030003 | FLAG + IDARUBICIN |
| 220006293 | 220002436 | null | 80 | Curative (C) | null | 2017-06-08 | AML 19 TRIAL | Y | N | 220030003 | AML19 TRIAL |
| 220006294 | 220002437 | 1.67 | 109.9 | Curative (C) | 2015-05-01 | 2015-05-01 | FLAG + Idarubicin | null | null | 220030010 | FLAG + IDARUBICIN |
| 220006295 | 220002437 | null | null | Curative (C) | 2015-06-17 | 2015-07-02 | null | null | N | 220030010 | NOT MATCHED |
| 220006296 | 220002437 | null | 65.8 | Curative (C) | 2014-08-29 | 2014-09-02 | FLAG + Idarubicin | 02 | N | 220030010 | FLAG + IDARUBICIN |
| 220006297 | 220002437 | 0 | null | null | 2016-11-20 | 2017-02-09 | Nilotinib | N | N | 220030010 | NILOTINIB |
| 220006298 | 220002437 | 1.7 | 91.4 | Curative (C) | null | 2015-05-10 | AML 19 TRIAL | 1 | N | 220030010 | AML19 TRIAL |
| 220006299 | 220002437 | 1.59 | 77 | Palliative (P) | 2017-11-04 | 2017-11-04 | null | N | N | 220030010 | NOT MATCHED |
| 220006300 | 220002438 | null | null | Palliative (P) | null | 2017-02-03 | Nilotinib | N | N | 220030022 | NILOTINIB |
| 220006301 | 220002438 | null | null | Palliative (P) | 2015-02-26 | 2015-02-26 | null | null | N | 220030022 | NOT MATCHED |
| 220006302 | 220002438 | 1.77 | 78.9 | Curative (C) | null | 2015-05-02 | AML 19 TRIAL | Y | N | 220030022 | AML19 TRIAL |
| 220006303 | 220002439 | 0 | 85 | Curative (C) | 2015-11-21 | 2015-11-22 | DAUNORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | Y | N | 220030028 | NOT MATCHED |
| 220006304 | 220011382 | null | 0 | Adjuvant (A) | null | 2015-11-19 | Nilotinib | N | N | 220030030 | NILOTINIB |
| 220006305 | 220002440 | 1.15 | 38.1 | Palliative (P) | 2015-04-10 | 2015-04-11 | AML 19 TRIAL + CYTARABINE + FLUDARABINE + IDARUBICIN + mylotarg | N | N | 220030035 | NOT MATCHED |
| 220006306 | 220002440 | 1.67 | 82.2 | Curative (C) | 2013-04-08 | 2013-04-12 | FLAG + Idarubicin | 02 | N | 220030035 | FLAG + IDARUBICIN |
| 220006307 | 220002441 | 0 | null | Disease modification (D) | null | 2013-04-12 | Nilotinib | 2 | N | 220030037 | NILOTINIB |
| 220006308 | 220002442 | 1.88 | 76.7 | Curative (C) | 2014-05-27 | 2014-05-27 | AML 19 TRIAL | 01 | N | 220030038 | AML19 TRIAL |
| 220006309 | 220002442 | 0 | 148.5 | Adjuvant (A) | 2016-02-13 | 2016-02-16 | Nilotinib | 02 | N | 220030038 | NILOTINIB |
| 220006310 | 220002443 | null | 97.5 | Disease modification (D) | 2018-04-02 | 2018-08-03 | Nilotinib | N | N | 220030042 | NILOTINIB |
| 220006311 | 220002444 | 1.76 | 71.4 | Curative (C) | 2017-10-18 | 2017-10-21 | AML 19 TRIAL | N | N | 220030046 | AML19 TRIAL |
| 220006312 | 220002445 | null | 98 | Curative (C) | 2015-12-09 | 2016-12-18 | Nilotinib | 02 | N | 220030047 | NILOTINIB |
| 220006313 | 220002445 | 1.59 | 54.5 | Curative (C) | 2014-11-28 | 2014-12-01 | AML 19 TRIAL | Y | N | 220030047 | AML19 TRIAL |
| 220006314 | 220002445 | null | 19.9 | Curative (C) | 2014-08-24 | 2014-08-24 | null | 1 | Y | 220030047 | NOT MATCHED |
| 220006315 | 220002446 | 1.68 | 68.6 | Curative (C) | 2017-02-16 | 2017-02-16 | AML 19 TRIAL | 01 | N | 220030052 | AML19 TRIAL |
| 220006316 | 220002446 | 1.76 | null | Curative (C) | 2016-10-03 | 2016-10-06 | FLAG + Idarubicin | 99 | N | 220030052 | FLAG + IDARUBICIN |
| 220006317 | 220002446 | 1.94 | 101.8 | Curative (C) | 2014-11-16 | 2014-11-16 | FLAG + Idarubicin | 01 | N | 220030052 | FLAG + IDARUBICIN |
| 220006318 | 220002447 | 1.78 | 84.6 | Curative (C) | 2013-08-07 | 2013-08-07 | FLAG + Idarubicin | N | N | 220030058 | FLAG + IDARUBICIN |
| 220006319 | 220002447 | 0 | 78 | Curative (C) | 2013-11-01 | 2013-11-01 | Nilotinib | N | N | 220030058 | NILOTINIB |
| 220006320 | 220016123 | 0 | 0 | Not known (9) | 2013-09-26 | 2014-01-16 | Nilotinib | 2 | N | 220030065 | NILOTINIB |
| 220006321 | 220016123 | 1.66 | 66.6 | Curative (C) | 2017-07-18 | 2017-07-19 | AML 19 TRIAL | Y | N | 220030065 | AML19 TRIAL |
| 220006322 | 220016123 | 1.79 | 62.9 | Curative (C) | 2014-12-17 | 2014-12-23 | AML 19 TRIAL | Y | N | 220030065 | AML19 TRIAL |
| 220006323 | 220002448 | 1.73 | 102.6 | Curative (C) | 2015-08-25 | 2015-08-26 | AML 19 TRIAL | 01 | N | 220030072 | AML19 TRIAL |
| 220006324 | 220002448 | 1.72 | 0 | Palliative (P) | 2016-10-02 | 2016-10-02 | AML MyeChild | Y | N | 220030072 | NOT MATCHED |
| 220006325 | 220016124 | 1.5 | 101 | Curative (C) | 2016-07-06 | 2016-07-06 | FLAG + Idarubicin | N | N | 220030075 | FLAG + IDARUBICIN |
| 220006326 | 220016124 | null | null | Disease modification (D) | 2015-12-30 | 2015-12-30 | Nilotinib | N | N | 220030075 | NILOTINIB |
| 220006327 | 220016124 | 0.91 | 56 | Curative (C) | 2016-09-14 | 2016-09-14 | null | N | N | 220030075 | NOT MATCHED |
| 220006328 | 220016124 | 1.68 | 78 | Adjuvant (A) | 2015-04-23 | 2015-04-23 | AML 19 TRIAL | 2 | N | 220030075 | AML19 TRIAL |
| 220006329 | 220002449 | 1.79 | 62 | Curative (C) | 2017-06-12 | 2017-06-12 | FLAG + Idarubicin | N | N | 220030087 | FLAG + IDARUBICIN |
| 220006330 | 220002449 | 1.57 | 78.5 | Curative (C) | 2017-03-15 | 2017-03-15 | AML 19 TRIAL | Y | N | 220030087 | AML19 TRIAL |
| 220006331 | 220002449 | 1.63 | 77 | Disease modification (D) | 2016-12-27 | 2017-01-03 | AML 19 TRIAL | 1 | N | 220030087 | AML19 TRIAL |
| 220006332 | 220002450 | 1.66 | 78.3 | Curative (C) | 2015-12-14 | 2015-12-15 | FLAG + Idarubicin | 02 | N | 220030093 | FLAG + IDARUBICIN |
| 220006333 | 220002450 | 1.5 | 68.6 | Curative (C) | 2016-05-11 | 2016-05-17 | FLAG + Idarubicin | 2 | N | 220030093 | FLAG + IDARUBICIN |
| 220006334 | 220002450 | null | 93.8 | Curative (C) | 2013-04-12 | 2013-04-12 | FLAG + Idarubicin | N | N | 220030093 | FLAG + IDARUBICIN |
| 220006335 | 220002451 | 0 | null | Curative (C) | 2017-06-24 | 2017-07-17 | Nilotinib | N | N | 220030106 | NILOTINIB |
| 220006336 | 220002451 | 1.88 | null | Curative (C) | 2014-01-23 | 2014-01-25 | AML 19 TRIAL | 01 | N | 220030106 | AML19 TRIAL |
| 220006337 | 220002452 | 1.8 | 66.5 | Curative (C) | 2015-04-20 | 2015-05-01 | AML 19 TRIAL | Y | N | 220030110 | AML19 TRIAL |
| 220006338 | 220002452 | 1.66 | 85.5 | Curative (C) | 2015-05-28 | 2015-05-29 | AML 19 TRIAL | Y | N | 220030110 | AML19 TRIAL |
| 220006339 | 220002452 | null | null | Disease modification (D) | 2017-03-13 | 2017-03-13 | Nilotinib | 02 | null | 220030110 | NILOTINIB |
| 220006340 | 220002452 | 1.59 | 68.4 | Curative (C) | 2015-07-01 | 2015-07-11 | AML 19 TRIAL | 1 | N | 220030110 | AML19 TRIAL |
| 220006341 | 220002452 | 0 | 0 | Unknown (U) | 2016-06-30 | 2016-06-30 | Nilotinib | N | N | 220030110 | NILOTINIB |